发明名称 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF.
摘要 <p>The present invention provides a novel carboxylic acid compound, a salt thereof or a hydrate of them useful as an insulin sensitizer, and a medicament comprising the compound as an active ingredient. That is, the present invention provides a carboxylic acid compound represented by the following formula, a salt thereof, an ester thereof or a hydrate of them. <CHEM> Wherein R<1> represents a hydrogen atom, hydroxyl group, halogen, carboxyl group, or a C1-6 alkyl group etc., each of which may have one or more substituents; L represents a single bond, or a C1-6 alkylene group, a C2-6 alkenylene group or a C2-6 alkynylene group, each of which may have one or more substituents; M represents a single bond, or a C1-6 alkylene group, a C2-6 alkenylene group or a C2-6 alkynylene group, each of which may have one or more substituents; T represents a single bond, or a C1-3 alkylene group, a C2-3 alkenylene group or a C2-3 alkynylene group, each of which may have one or more substituents; W represents a carboxyl group; - - - represents a single bond etc. ; X represents a single bond, oxygen atom, a group represented by -NR<X1>CQ<1>O- (wherein Q<1> represents an oxygen atom or sulfur atom; and R<X1> represents a hydrogen atom, formyl group, or a C1-6 alkyl group etc., each of which may have one or more substituents), -OCQ<1>NR<X1>- (wherein Q<1> and R<X1> are as defined above), -CQ<1>NR<x1>O- (wherein Q<1> and R<X1> are as def ined above), ONR<X1>CQ<1>- (wherein Q<1> and R<X1> are as defined above), - Q<2>SO2- (wherein Q<2> is an oxygen atom or -NR<X10>- (wherein R<X10> represents a hydrogen atom, formyl group, or a C1-6 alkyl group etc., each of which may have one or more substituents)) or -SO2Q<2>- (wherein Q<2> is as defined above), (wherein, provided that R<X2> and R<X3>, and/or R<X4> and R<X5> may together form a ring, Q<3> and Q<4> are the same as or different from each other and each represents an oxygen atom, (O)S(O) or NR<X10> (wherein NR<X10> is as defined above)); Y represents a 5- to 14-membered aromatic group etc., which may have one or more substituents and one or more hetero atoms; and the ring Z represents a 5-to 14-membered aromatic group which may have 0 to 4 substituents and one or more hetero atoms, and wherein part of the ring may be saturated.</p>
申请公布号 MXPA03009565(A) 申请公布日期 2004.02.12
申请号 MX2003PA09565 申请日期 2002.04.18
申请人 EISAI CO., LTD 发明人 MASANOBU SHINODA
分类号 C07C59/64;A61P1/00;A61P1/04;A61P1/18;A61P3/04;A61P3/06;A61P3/10;A61P9/10;A61P19/10;A61P25/28;A61P29/00;A61P35/00;A61P37/02;C07C59/58;C07C59/68;C07C59/72;C07C233/25;C07C235/24;C07C251/48;C07C251/52;C07C251/54;C07C255/37;C07C255/54;C07C259/10;C07C271/14;C07C271/16;C07C271/22;C07C271/28;C07C271/58;C07C309/73;C07C309/75;C07C311/19;C07C317/18;C07C317/22;C07C323/20;C07D209/08;C07D209/18;C07D209/24;C07D213/30;C07D213/65;C07D213/68;C07D213/73;C07D213/75;C07D215/14;C07D215/18;C07D215/26;C07D235/06;C07D235/12;C07D277/56;C07D295/096;C07D295/192;C07D307/79;C07D317/54;C07D413/12;C07D417/12;(IPC1-7):A61K31/192;C07D417/04;C07D333/16;C07D317/72;C07D295/18;C07D215/22;C07D215/20;C07D213/64;C07C59/90;C07C59/66;C07C311/17;C07C251/50;A61P43/00;A61K31/470;A61K31/47;A61K31/44;A61K31/427;A61K31/425;A61K31/40;A61K31/381;A61K31/357;A61K31/27 主分类号 C07C59/64
代理机构 代理人
主权项
地址